Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at [email protected].
Comparing data from patients with primary nephrotic syndrome to matched controls in a 1:100 ratio, investigators found these patients were at a 19-fold greater risk of end-stage kidney disease and a 3-fold greater risk of acute coronary syndrome events.
Data from more than 1000 women in Australia suggests each incremental increase in abdominal aortic calcification was linked to a 3% increase in the risk of fall-related hospitalizations.
A case series of 7 patients from a pair of US medical centers details the treatment and presentation of patients with myocarditis-like illness after receiving a COVID-19 vaccine.
Results of an open-label randomized trial suggests targeted hypothermia among unconscious cardiac arrest patients may not provide mortality benefits compared to normothermic patients.
A study assessing levels of flourine in cosmetic products available in the US and Canada suggests many of these products could contain levels of chemicals that, over time, could cause harm.
Analysis of 2-year data from the GOULD Registry indicates new strategies are needed to address the suboptimal levels of lipid-lowering therapy intensification among patients with ASCVD and increased LDL-C.
A randomized trial comparing 3 dietary approaches, including 2 involving fasting, suggests the recently popularized approach does not provide any substantial benefits compared to a traditional diet.
A comparison of data from patients with cancer and ASCVD from a nationally representative survey suggests the financial burden of cardiovascular disease was similar to or exceeded the burden imposed by cancer.
A retrospective analysis of data from more than 30k patients with severe obesity suggests having a discussion about bariatric surgery with a clinician resulted in greater weight loss, regardless of if they underwent a bariatric procedure, but fewer than 9% had these discussions.
New research indicates improvements in cardiovascular health during young adulthood among patients with low baseline cardiovascular health could reduce the rates of premature cardiovascular disease as the population ages.
Data from the UK Biobank cohort details the increased risk of adverse health outcomes, including the development of diabetes and heart failure, among patients considered to have metabolically healthy obesity.
A recent review of data from within a major European-based database indicates women with PCOS were at a 26% greater risk of major adverse cardiovascular events when compared to matched controls without polycystic ovary syndrome.
An analysis of survey responses from 2013-2018 indicates many patients with a history of cardiovascular disease who use tobacco continue to do so, despite being aware of the increased risk associated with smoking and tobacco use.
A comparison of women with PCOS to matched controls indicates women with PCOS were at a 26% greater risk of experiencing major adverse cardiovascular events than their counterparts without polycystic ovary syndrome.
A study from Brown University demonstrates MagSafe technology used in the iPhone 12 Pro Max could interfere with cardiac implantable electronic devices.
The third of 5 slideshows included in our "A Need for Change" series, details the work of Task Force 3 from the American Heart Association/American College of Cardiology Consensus Conference on Professionalism and Ethics, which sought to identify shortcomings and avenues for improving the well-being of cardiologists and cardiology professionals.
A cross-sectional analysis of NHANES data paints a grim picture related to rates of patients with diabetes achieving goals for glycemic, blood pressure, and lipid control.
An analysis of data from nearly 500k patients suggests patients with diabetes experiencing frequent insomnia were at an 87% increased risk of all-cause mortality compared to those with neither sleep disturbances nor diabetes.
An analysis of survey data from cardiologists in multiple regions throughout the world portrays a field in need of reform, with more than 4-in-10 reporting a hostile work environment and some form of discrimination reported by 3-in-10 cardiologists.
An analysis of food frequency questionnaire and biomarker data from more than 7000 adults indicates consumption of 2 or more servings of whole fruit per day was associated with 36% lower odds of developing diabetes in the next half-decade.
The FDA has announced the approval of semaglutide 2.4 mg (Wegovy) for chronic weight management in patients with obesity or overweight—the first drug to receive such an approval from the FDA in more than half a decade.
A look at more than 2800 older patients with type 1 diabetes indicates experiencing severe glycemic events was linked to an increased risk of developing dementia.
Medtronic has halted sale of the HeartWare Ventricular Assist Device System after more than 100 complaints were filed, including 14 reports of mortality.
After receiving more than 100 complaints, including some involving death, Medtronic has halted sale of the HeartWare Ventricular Assist Device System and the FDA has issued a warning to clinicians to stop new implants of the device.
A retrospective look at patients who initated real-time CGM versus noninitiators indicates CGM use resulted in significant reductions in HbA1c and also reduced the number of outpatient and telephone visits among patients with type 1 diabetes and type 2 diabetes.
Simultaneously published in JAMA, the PER DIEM and STROKE-AF trials demonstrate the ability of Medtronic's insertable cardiac monitor, Reveal LlNQ, to improve detection of atrial fibrillation in patients with a history of stroke.
Data from AACE 2021 suggests the risk of cardiovascular disease was 15% greater among patients with thyroid cancer who underwent thyroidectomy than the general population, but found no significant difference in risk of cardiac mortality and atrial fibrillation.
A trial of more than 150 patients with type 2 diabetes using basal insulin without prandial insulin suggests CGM use among these patients could lower HbA1c and improve time in target range compared to traditional blood glucose monitoring.
Analysis of claims data from the Symphony database offers clinicians greater insight into the impact of diabetes, both type 1 and type 2, on thyroid eye disease in US patients.
The AHA has released a scientific statement highlighting the importance of prescribing physical activity as a first-line treatment in patient populations with elevated blood pressure or elevated cholesterol.
